Clinical Trial

Repeated Low-Level Red-Light Therapy for Shortening Axial Length

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this clinical trial is to confirm the incidence and magnitude of axial length shortening after RLRL therapy in Chinese high myopia children and teenagers.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-09-20; most recent amendment 2025-03-28.
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-11-03
Trial Details
NCT Number NCT05550740
Lead Sponsor Shanghai Eye Disease Prevention and Treatment Center
Conditions High Myopia, Refractive Errors, Eye Diseases
Enrollment 30 participants
Start Date 2022-11-19
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-23 (estimated)
Updated on ClinicalTrials.gov 2025-03-30